Efficacy and Safety of Neoadjuvant Envafolimab Combined With Albumin-bound Paclitaxel and Carboplatin for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
Clinical trial NCT07266493 · RECRUITING
Trial details
- NCT number
- NCT07266493
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-01
- Primary completion
- 2026-06-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.